Please use this identifier to cite or link to this item:
Title: Impact of 2-deoxy-2[F-18]fluoro-D-glucose Positron Emission Tomography on the management of patients with advanced melanoma.
Austin Authors: Harris, Marion T;Berlangieri, Salvatore U ;Cebon, Jonathan S ;Davis, Ian D;Scott, Andrew M 
Affiliation: Centre for Positron Emission Tomography, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 8-Jul-2005
Publication information: Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging; 7(4): 304-8
Abstract: Accurate staging of patients with melanoma is vital to guide appropriate treatment. 2-Deoxy-2-[F-18]fluoro-D-glucose (FDG)-positron emission tomography (PET) has been reported to be a sensitive and specific technique for the staging of advanced melanoma, however, few studies provide information regarding its impact on patient management.We retrospectively reviewed the FDG-PET scan results of 92 patients with melanoma who had 126 scans performed over a six-year period. These patients were seen at the specialist melanoma clinic at our Institution, and 84 patients (92%) had stage III or IV disease. FDG-PET scan results were correlated with computed tomography (CT) scans and other imaging when available, and with clinical follow-up of a minimum of three to six months. The impact of FDG-PET scans on patient management was also assessed.On a lesion-by-lesion analysis, FDG-PET had a sensitivity of 92%, a specificity of 88%, and an accuracy of 91%. FDG-PET correctly affected the clinical decision-making process in 40 of 126 patient studies (32%), particularly assisting in the selection of patients for surgery.FDG-PET has an important role in guiding the management of patients with advanced melanoma, particularly when surgery is contemplated.
Gov't Doc #: 16041590
DOI: 10.1007/s11307-005-0002-7
Journal: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging
Type: Journal Article
Subjects: Adult
False Negative Reactions
False Positive Reactions
Fluorodeoxyglucose F18.metabolism
Middle Aged
Neoplasm Staging
Positron-Emission Tomography.methods
Treatment Outcome
Appears in Collections:Journal articles

Files in This Item:
File SizeFormat 
16041590.pdf51.82 kBAdobe PDFView/Open
Show full item record

Page view(s)

checked on May 27, 2024


checked on May 27, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.